![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 47, 48607-48614, November 19, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subunit of Phosphatidylinositol 3'-Kinase Binds to and Stimulates the GTPase Activity of Rab Proteins*

¶


||**
From the
Cancer Research Unit, Health Research Division, Saskatchewan Cancer Agency, Saskatoon, Saskatchewan S7N 4H4, Canada and the Departments of
Biochemistry and ||Oncology, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada
Rab5 and Rab4 are small monomeric GTPases localized on early endosomes and function in vesicle fusion events. These Rab proteins regulate the endocytosis and recycling or degradation of activated receptor tyrosine kinases such as the platelet-derived growth factor receptor (PDGFR). The p85
subunit of phosphatidylinositol 3'-kinase contains a BH domain with sequence homology to GTPase activating proteins (GAPs), but has not previously been shown to possess GAP activity. In this report, we demonstrate that p85
has GAP activity toward Rab5, Rab4, Cdc42, Rac1 and to a lesser extent Rab6, with little GAP activity toward Rab11. Purified recombinant Rab5 and p85
can bind directly to each other and not surprisingly, the p85
-encoded GAP activity is present in the BH domain. Because p85
stays bound to the PDGFR during receptor endocytosis, p85
will also be localized to the same early endosomal compartment as Rab5 and Rab4. Taken together, the physical co-localization and the ability of p85
to preferentially stimulate the down-regulation of Rab5 and Rab4 GTPases suggests that p85
regulates how long Rab5 and Rab4 remain in their GTP-bound active state. Cells expressing BH domain mutants of p85 show a reduced rate of PDGFR degradation as compared with wild type p85 expressing cells. These cells also show sustained activation of the mitogen-activated protein kinase and Akt pathways. Thus, the p85
protein may play a role in the down-regulation of activated receptors through its temporal control of the GTPase cycles of Rab5 and Rab4.
Received for publication, August 25, 2004
* This work was supported in part by the Natural Sciences and Engineering Research Council and the Saskatchewan Cancer Agency Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Recipient of a Canadian Institutes of Health Research Regional Partnership Program doctoral award.
** To whom correspondence should be addressed: Cancer Research Unit, Health Research Division, Saskatchewan Cancer Agency, 20 Campus Dr., Saskatoon, Saskatchewan S7N 4H4, Canada. Tel.: 306-655-2538; Fax: 306-655-2898; E-mail: danderson{at}scf.sk.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. L. Houck, T. E. Fox, L. Sandirasegarane, and M. Kester Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signaling Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1657 - H1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, D. H. Anderson, Q. Liu, and Y. Zhou Mechanism of Influenza A Virus NS1 Protein Interaction with the p85{beta}, but Not the p85{alpha}, Subunit of Phosphatidylinositol 3-Kinase (PI3K) and Up-regulation of PI3K Activity J. Biol. Chem., August 22, 2008; 283(34): 23397 - 23409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Chamberlain, T. Chan, J. C. Oberg, A. D. Hawrysh, K. M. James, A. Saxena, J. Xiang, and D. H. Anderson Disrupted RabGAP Function of the p85 Subunit of Phosphatidylinositol 3-Kinase Results in Cell Transformation J. Biol. Chem., June 6, 2008; 283(23): 15861 - 15868. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Doi, K. Obayashi, T. Kadowaki, H. Fujii, and S. Koyasu PI3K is a negative regulator of IgE production Int. Immunol., April 1, 2008; 20(4): 499 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Deane, M. G. Kharas, J. S. Oak, L. N. Stiles, J. Luo, T. I. Moore, H. Ji, C. Rommel, L. C. Cantley, T. E. Lane, et al. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling Blood, April 1, 2007; 109(7): 2894 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Su, I. J. Lodhi, A. R. Saltiel, and P. D. Stahl Insulin-stimulated Interaction between Insulin Receptor Substrate 1 and p85{alpha} and Activation of Protein Kinase B/Akt Require Rab5 J. Biol. Chem., September 22, 2006; 281(38): 27982 - 27990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ignatiuk, J. P. Quickfall, A. D. Hawrysh, M. D. Chamberlain, and D. H. Anderson The Smaller Isoforms of Ankyrin 3 Bind to the p85 Subunit of Phosphatidylinositol 3'-Kinase and Enhance Platelet-derived Growth Factor Receptor Down-regulation J. Biol. Chem., March 3, 2006; 281(9): 5956 - 5964. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.J. Landon and T. Inagami Beyond the G Protein: The Saga of the Type 2 Angiotensin II Receptor Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 15 - 16. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |